By Maxime Schuchewytsch, IQVIA
As the science behind leading-edge therapeutics rapidly evolves, the clinical trials to prove the safety and efficacy of these drugs also become more complex. Biologically derived precision medicines require exact temperatures for shipping and storage and often expire quickly. Also, the kits often have disparate elements, such as multiple vials or prefilled syringes, whose individual volumes must be measured to monitor patient compliance.
The logistics behind getting these therapeutics from manufacturers to sites and patients are complex and risk stock outs or expensive, wasted IP. When closing out a study, manually recording and returning kits and completing patient paperwork is burdensome, causing delays. Sponsors, investigators, and site managers are all motivated to find advanced solutions to the supply chain complexities of today’s clinical trials to accelerate study timelines and reduce waste. Enhanced automation and integrations between systems can simplify these processes and ensure that sites and patients have the drugs they need when they need them.